Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors
about
Systematic review of influenza resistance to the neuraminidase inhibitorsInjectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)Exploring the mechanism of zanamivir resistance in a neuraminidase mutant: a molecular dynamics studyOseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza VirusesTracking oseltamivir-resistance in New Zealand influenza viruses during a medicine reclassification in 2007, a resistant-virus importation in 2008 and the 2009 pandemic.Molecular distribution of amino acid substitutions on neuraminidase from the 2009 (H1N1) human influenza pandemic virus.Effective, robust design of community mitigation for pandemic influenza: a systematic examination of proposed US guidance.Targeting pandemic influenza: a primer on influenza antivirals and drug resistance.Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemicPandemism of swine flu and its prospective drug therapy.Full genome comparison and characterization of avian H10 viruses with different pathogenicity in Mink (Mustela vison) reveals genetic and functional differences in the non-structural gene.Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.Phylogenetic analysis of neuraminidase gene of H9N2 avian influenza viruses isolated from chicken in Iran during 2010-2011.Intersubtype Reassortments of H5N1 Highly Pathogenic Avian Influenza Viruses Isolated from Quail.Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infectionGenetic strategy to prevent influenza virus infections in animalsOseltamivir resistance among influenza viruses: surveillance in northern Viet Nam, 2009-2012.In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses.A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade.Antiviral treatment of influenza in South Korea.Synthesis and In Vitro Anti-Influenza Virus Evaluation of Novel Sialic Acid (C-5 and C-9)-Pentacyclic Triterpene Derivatives.Virological Surveillance of Influenza A Subtypes Isolated in 2014 from Clinical Outbreaks in Canadian Swine.The inhibitory effect of dehydroepiandrosterone and its derivatives against influenza A virus in vitro and in vivo.Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring.Identification of influenza virus inhibitors targeting NS1A utilizing fluorescence polarization-based high-throughput assay.Sequence analysis of the neuraminidase genes of avian influenza A viruses isolated from live bird markets in the United States.Anti-influenza therapy: the emerging challenge of resistance
P2860
Q21261835-982A0638-5B0B-4701-842D-BEC8683F29AEQ24645944-CA5F9E96-FBE7-420F-BA54-ED4395643F33Q28483631-D6738FC4-740F-40A6-AC2C-D95920128AA4Q28548477-6358A382-8DCD-4AF8-A6BC-F9834F8B69F1Q30352557-A3428EDA-3D28-40F9-9BC3-D82A949770E6Q30352689-1D08C145-B748-4BEE-ABBC-786CE24BF534Q30370409-BA90842D-C56E-419C-975E-52857A461D5CQ30387832-5FA058E6-A198-4D33-BEEB-AB6E912A3ABEQ30415228-95A7A100-18A1-4A6C-AD8A-583E1AEB6D84Q30420391-CE6EDDD9-5963-436B-8EB6-071ED08489F8Q34019902-B75208CA-759F-41A6-8938-7B52EB8FAEE9Q34120005-52E72FE8-F88F-4534-95D6-FDC14F45686BQ34800749-A83D9B3D-AF40-434D-97BF-325F3F13667AQ35930657-184633AF-A294-4CEC-9C21-DB3D6EF99CF0Q36993551-88FE872C-E868-49F2-B655-4F43EFA2D7F8Q37082747-F7E454C8-2374-4DF8-B081-AF3F1205C28DQ37146912-C8C11EF4-7690-4DF1-A51D-5770CDC65958Q37392896-2B61F464-174A-4779-B15F-B7C220CEFEE6Q38209673-47266757-598E-4EA2-963A-9EA4918BF06EQ38401883-75562462-E005-4A36-8728-64383181CF1EQ38699365-ED56C6E2-32CD-4E3B-98FC-BE2919A7D24BQ40277337-0236B980-46BC-4DE7-AEA4-3D200DF8068FQ40577964-3ABC382F-3E3B-42FB-868B-D93F610A5616Q41095623-AFF86BF0-9833-4FB5-88A7-93A16639285CQ45360594-A108AA87-6FA2-4DA5-9F3E-E44CE966DD39Q48058751-3BB5FFB8-683D-48DE-B0BD-3BA0C5438CE4Q58066873-3791E405-3E0F-4230-B7EA-DD55F9F77561
P2860
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors
@ast
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors
@en
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors
@en-gb
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors
@nl
type
label
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors
@ast
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors
@en
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors
@en-gb
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors
@nl
prefLabel
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors
@ast
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors
@en
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors
@en-gb
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors
@nl
P2860
P356
P1476
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors
@en
P2093
Hui-Ting Ho
P2860
P304
P356
10.1586/14787210.4.5.795
P407
P577
2006-10-01T00:00:00Z